Zimmer Biomet Holdings Inc. announced its first-quarter 2022 financial results, highlighted by increased net sales and the completion of the spinoff of ZimVie, according to a press release.
The company reported a first-quarter net sales of $1.663 billion, an increase of 3.9% from the prior year period. The company also reported net earnings of $73 million from continuing operations for the first quarter.
“We are encouraged by the better-than-expected results seen in Q1, driven by COVID recovery and continued execution by the Zimmer Biomet team. This performance increases our confidence